Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Biotechnology and Pharmaceuticals Breast cancer Bristol Myers Squibb business Cancer Clinical trial Conditions and Diseases Deal Eli Lilly European Commission European Union FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Margaret Hamburg Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News- Medicago Awarded $21 million from the US Department of Defense
- Regulators, Industry Disagree Over Noncritical Process Parameters at CMC Forum
- RecipharmCobra Biologics Receives Patent for Antibiotic-Free Plasmid Maintenance System
- President's Council and HHS Call for Overhaul of Pandemic Response Programs
- Nabi Receives Key Patent for Nicotine Vaccines, Enters Manufacturing Agreement with Diosynth
Clinical Trials NewsBlogroll
-
Meta
Tag Archives: Merck
Pharma Layoffs Continue
It’s been another tough few weeks for pharma employees as four more companies handed out pink slips in an effort to trim bottom lines.
Elan cut 14 percent of its global work force last Wednesday as a part of an ongoing strategic review process. The company announced that it would postpone biologics manufacturing, redesign R&D in [...]
JP Morgan Healthcare Conference:
It’s All About "Money…Rather the Economy!"
JP Morgan’s Healthcare Conference has always been about financing, but money has never been the main focus like it is at this year’s annual gathering in San Francisco. The hallmark of this investment meeting has been innovation, with companies passionately pitching their new product or technology and management team’s capability to execute on a [...]
Posted in Events Also tagged Art Levinson, conference, DNA, Erich Hunziker, Gene, Genentech, healthcare, JP Morgan, NME, Richard Clark, Roche, Ted Kennedy 1 Comment
FDA Declares: Keep Taking Your Vytorin
It’s official. Vytorin (ezetimibe/simvastatin) still does what it’s supposed to do—significantly decrease LDL cholesterol.
FDA, yesterday, released its assessment of the now-notorious ENHANCE trial—which tested whether Vytorin was better than simvastatin alone in reducing arterial plaque in a group of patients with severe genetic high cholesterol. It wasn’t, and publication of the study set off a [...]
Posted in Regulatory Also tagged ENHANCE, FDA, IMPROVE-IT, Schering Plough, simvastatin, Vytorin Leave a comment
Merck to Axe 7,200 Positions
Not much in the way of good news at Merck this morning. The pharma giant announced that it is revising its financial guidelines through 2010, and eliminating 7,200 positions by 2011. The move is expected to save the company $3.8 billion to $4.2 billion through 2013.
The layoffs will be staggered throughout different parts of the [...]
Posted in Sales, Strategy Also tagged Gardasil, jobs, layoffs, Richard T. Clark, Vytorin, Zetia Leave a comment

Schering-Plough to Merge with Merck for $41.1 Billion